TickerFacts.

Company research / CURLF

Curaleaf Holdings, Inc. (CURLF)

Build a valuation ↗↓ Download CSV

CIK 0001756770 · OTC · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Curaleaf Holdings, Inc. reported revenue of $1.27B. Revenue fell 5.0% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $1.32B.

Key ratios (year ended 2025-12-31)

49.8%
Gross margin
2.0%
Operating margin
-18.2%
Net margin
-30.6%
Return on year-end equity
-5.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-09-16

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue$1.32B$1.27B$1.33B$1.35B$1.28B$1.20B
Cost of Revenue$665.68M$637.11M$693.52M$732.18M$649.00M$626.16M
Gross Profit$649.58M$631.02M$640.78M$614.45M$626.42M$569.83M
R&D Expensen/a$805.0K$1.42Mn/an/an/a
Operating Income$14.81M$25.45M$24.74M$42.88M$64.99M$58.57M
Depreciation & Amortization$195.08M$196.61M$231.46M$195.88M$155.98M$120.54M
EBITDA$209.89M$222.06M$256.20M$238.76M$220.97M$179.12M
Net Income-$34.54M-$231.07M-$215.42M-$281.20M-$370.10M-$205.94M
EPS (Diluted)n/a-$0.35-$0.32-$0.39-$0.52-$0.29
Total Assets$2.81B$2.85B$2.95B$3.10B$3.41B$3.11B
Total Liabilities$1.95B$2.01B$1.96B$1.93B$2.01B$1.44B
Long-Term Debt$611.54M$548.65M$568.62M$587.77M$622.67M$459.88M
Shareholders' Equity$867.46M$756.35M$861.21M$1.05B$1.28B$1.55B
Cash & Equivalents$94.59Mn/an/an/a$163.18M$299.33M
Operating Cash Flow$140.97M$137.71M$163.62M$75.26M$46.40M-$58.28M
Capital Expenditures$65.56M$63.44M$92.44M$65.45M$134.64M$171.96M
Free Cash Flow$75.42M$74.27M$71.19M$9.81M-$88.24M-$230.24M
Shares Outstanding264.74Mn/a750.06M733.73M717.49Mn/a
Weighted Average Diluted Sharesn/a762.09M740.83M724.12M711.16M698.76M
EPS (Basic)n/a-$0.35-$0.32-$0.39-$0.52-$0.29